CynosBio
Developer of regenerative medicine technology designed for knee osteoarthritis. The company develops human autologous oral mucosa-derived epithelial cell sheets using human amniotic membrane substrate...
Valuation
$26.9M
Latest known
Share Price
N/A
Total Raised
$12.8M
Last Round
N/A